Surgery Partners Form 144: Insider Sale Notice

Surgery Partners, Inc. filed a Form 144 disclosing proposed sales of vested common shares by an affiliate/broker.

Rhea-AI Filing Summary

Surgery Partners, Inc. filed a Form 144 disclosing proposed sales of vested common shares by an affiliate/broker. The excerpt lists 1,039 shares vesting on 02/28/2026 and 6,697 shares vesting on 03/02/2026.

Transactions are presented as equity compensation vesting and proposed resale under Form 144.

Insights

Securities Attorney

Form 144 lists proposed resale of vested equity, a routine Section 16 disclosure.

Form 144 is a regulatory notice that permits resale by persons subject to Rule 144; the entries show vesting dates of 02/28/2026 and 03/02/2026

Cash‑flow treatment and broker specifics are not detailed in the excerpt; subsequent filing updates would show execution details if sales occur.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Surgery Partners' Form 144 disclose (SGRY)?

It discloses proposed resale of vested common shares under Rule 144. The excerpt lists 1,039 shares vesting on 02/28/2026 and 6,697 shares vesting on 03/02/2026. No sale execution details are shown in the excerpt.

Does the Form 144 show shares already sold for SGRY?

No; the excerpt lists securities to be sold and vesting events, not completed trades. It presents proposed resale of vested equity and includes vesting dates but no executed sale prices or dates.

Who is listed as the broker or holder on the Form 144?

UBS Financial Services Inc. appears in the excerpt with an address and a numeric line, suggesting broker involvement. The filing shows UBS Financial Services Inc. with the Weehawken, NJ address associated with the securities line.

Are the amounts material to Surgery Partners (SGRY) outstanding shares?

The excerpt provides only the specific vested share counts (1,039 and 6,697) and dates; it does not provide total shares outstanding or dilution context, so materiality versus outstanding shares cannot be determined from this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 11:45 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001966798
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Surgery Partners, Inc.
SEC File Number	001-37576
Address of Issuer	340 Seven Springs Way, Suite 600 Brentwood TENNESSEE 37027
Phone	(615) 234-5900
Name of Person for Whose Account the Securities are To Be Sold	Danielle Burkhalter
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	7736	105238.53	129419836	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/28/2026	equity vesting	Surgery Partners, Inc.			1039	02/28/2026	equity compensation
common	03/02/2026	equity vesting	Surgery Partners, Inc.			6697	03/02/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Danielle Burkhalter
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)